prof. dr. Pieter Hindryckx
Show
Sort by
-
Early prediction of response to vedolizumab in patients with active inflammatory bowel disease : a prospective real-life multicentre cohort study
-
Effectiveness of ustekinumab in refractory Crohn's disease : a real-life experience in a tertiary referral centre
-
- Journal Article
- A1
- open access
Charting extracellular transcriptomes in the human biofluid RNA atlas
-
Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients
-
- Conference Paper
- C3
- open access
Retrospective study of the effectiveness and safety of Ustekinumab in refractory Crohn's Disease
(2019) UEG Week 2019 Poster Presentations. In UNITED EUROPEAN GASTROENTEROLOGY JOURNAL 7(8, suppl.). p.644-644 -
- Conference Paper
- C3
- open access
Efficacy of Ustekinumab intensification and re-induction in Crohn’s disease patients with insufficient or loss of response
(2019) UEG Week 2019 Poster Presentations. In UNITED EUROPEAN GASTROENTEROLOGY JOURNAL 7(8, suppl.). p.645-645 -
- Journal Article
- A2
- open access
Endoscopic ultrasound-guided drainage of the biliary system : techniques, indications and future perspectives
-
Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients
-
A novel device for the endoscopic management of buried bumper syndrome
-
Vedolizumab induces endoscopic and histologic remission in patients with Crohn’s disease